These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17285226)

  • 21. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.
    Kahbazi M; Ghoreishi A; Rahiminejad F; Mohammadi MR; Kamalipour A; Akhondzadeh S
    Psychiatry Res; 2009 Aug; 168(3):234-7. PubMed ID: 19439364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selegiline in the treatment of hypersomnolence in myotonic dystrophy: a pilot study.
    Antonini G; Morino S; Fiorelli M; Fiorini M; Giubilei F
    J Neurol Sci; 1997 Apr; 147(2):167-9. PubMed ID: 9106123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I.
    Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
    Acta Neurol Scand; 2007 Apr; 115(4):265-70. PubMed ID: 17376125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil.
    Saletu MT; Anderer P; Saletu-Zyhlarz GM; Mandl M; Arnold O; Nosiska D; Zeitlhofer J; Saletu B
    Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):20-32. PubMed ID: 15538594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of participation in myotonic dystrophy: reliability of the LIFE-H.
    Gagnon C; Mathieu J; Noreau L
    Neuromuscul Disord; 2006 Apr; 16(4):262-8. PubMed ID: 16545567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of modafinil in patients with epilepsy.
    Artsy E; McCarthy DC; Hurwitz S; Pavlova MK; Dworetzky BA; Lee JW
    Epilepsy Behav; 2012 Apr; 23(4):405-8. PubMed ID: 22420936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modafinil: new indication. For a minority of patients with sleep apnoea.
    Prescrire Int; 2007 Jun; 16(89):102-3. PubMed ID: 17582924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1--the patients' perspective.
    Hilton-Jones D; Bowler M; Lochmueller H; Longman C; Petty R; Roberts M; Rogers M; Turner C; Wilcox D
    Neuromuscul Disord; 2012 Jul; 22(7):597-603. PubMed ID: 22425060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
    Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
    J Psychosom Res; 2007 May; 62(5):571-9. PubMed ID: 17467412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modafinil and unconstrained motor activity in schizophrenia: double-blind crossover placebo-controlled trial.
    Farrow TF; Hunter MD; Haque R; Spence SA
    Br J Psychiatry; 2006 Nov; 189():461-2. PubMed ID: 17077439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J; Pliszka SR
    J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous melatonin predicts efficacy of exogenous melatonin in consolidation of fragmented wrist-activity rhythm of adult patients with developmental brain disorders: a double-blind, placebo-controlled, crossover study.
    Laakso ML; Lindblom N; Leinonen L; Kaski M
    Sleep Med; 2007 Apr; 8(3):222-39. PubMed ID: 17368097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of fesoterodine on quality of life: pooled data from two randomized trials.
    Kelleher CJ; Tubaro A; Wang JT; Kopp Z
    BJU Int; 2008 Jul; 102(1):56-61. PubMed ID: 18564231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome.
    Robinson D; Cardozo L; Terpstra G; Bolodeoku J;
    BJU Int; 2007 Oct; 100(4):840-5. PubMed ID: 17822465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Problem-focused coping and satisfaction with activities of daily living in individuals with muscular dystrophy and postpolio syndrome.
    Nätterlund B; Ahlström G
    Scand J Caring Sci; 1999; 13(1):26-32. PubMed ID: 10476191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dehydroepiandrosterone for myotonic dystrophy type 1.
    Pénisson-Besnier I; Devillers M; Porcher R; Orlikowski D; Doppler V; Desnuelle C; Ferrer X; Bes MC; Bouhour F; Tranchant C; Lagrange E; Vershueren A; Uzenot D; Cintas P; Solé G; Hogrel JY; Laforêt P; Vial C; Vila AL; Sacconi S; Pouget J; Eymard B; Chevret S; Annane D
    Neurology; 2008 Aug; 71(6):407-12. PubMed ID: 18678823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
    Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M
    Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants.
    Lam JY; Freeman MK; Cates ME
    Ann Pharmacother; 2007 Jun; 41(6):1005-12. PubMed ID: 17519297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.